IT1258939B - Linear or cyclic hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts, their preparation and pharmaceutical compositions containing them - Google Patents
Linear or cyclic hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IT1258939B IT1258939B ITFI920128A ITFI920128A IT1258939B IT 1258939 B IT1258939 B IT 1258939B IT FI920128 A ITFI920128 A IT FI920128A IT FI920128 A ITFI920128 A IT FI920128A IT 1258939 B IT1258939 B IT 1258939B
- Authority
- IT
- Italy
- Prior art keywords
- tachyquinine
- pharmaceutically acceptable
- acceptable salts
- linear
- preparation
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010007270 Carcinoid syndrome Diseases 0.000 abstract 1
- 206010052402 Gastrointestinal hypermotility Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010029240 Neuritis Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 208000024780 Urticaria Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts of general formula: X-NH-CHR1-W-CHR3-CO-A1-A2-A3-βA1a-Y which are useful for the treatment of diseases and in which the tachyquinines have a pathogenetic role in particular against arthritis, asthma, inflammations, tumoural growths, gastrointestinal hypermotility, Huntington's disease, neuritis, neuralgia, migraine, hypertension, urinary incontinence, urticaria, carcinoid syndrome symptoms, influenza and chills are described.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI920128A IT1258939B (en) | 1992-06-19 | 1992-06-19 | Linear or cyclic hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts, their preparation and pharmaceutical compositions containing them |
JP5503277A JPH06509571A (en) | 1991-08-08 | 1992-08-03 | Process for producing cyclic hexapeptides as tachykinin antagonists and pharmaceutical compounds thereof |
EP92916106A EP0606222A1 (en) | 1991-08-08 | 1992-08-03 | Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
PCT/EP1992/001760 WO1993003059A1 (en) | 1991-08-08 | 1992-08-03 | Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
AU23875/92A AU2387592A (en) | 1991-08-08 | 1992-08-03 | Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
PT100764A PT100764A (en) | 1991-08-08 | 1992-08-07 | CYCLIC HEXAPEPTIDES OF TAQUIQUININS AND THEIR PHARMACEUTICALLY ACCEPTANT SALTS, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ANALOGS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI920128A IT1258939B (en) | 1992-06-19 | 1992-06-19 | Linear or cyclic hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts, their preparation and pharmaceutical compositions containing them |
Publications (3)
Publication Number | Publication Date |
---|---|
ITFI920128A0 ITFI920128A0 (en) | 1992-06-19 |
ITFI920128A1 ITFI920128A1 (en) | 1993-12-19 |
IT1258939B true IT1258939B (en) | 1996-03-08 |
Family
ID=11350134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITFI920128A IT1258939B (en) | 1991-08-08 | 1992-06-19 | Linear or cyclic hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts, their preparation and pharmaceutical compositions containing them |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1258939B (en) |
-
1992
- 1992-06-19 IT ITFI920128A patent/IT1258939B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITFI920128A1 (en) | 1993-12-19 |
ITFI920128A0 (en) | 1992-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE290015T1 (en) | CYCLOSPORINE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS | |
AR012588A1 (en) | A SERINE PROTEASE INHIBITOR, A COMPREHENSIVE PHARMACEUTICAL COMPOSITION AND A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION | |
BR9609063A (en) | Dinucleotides useful for the treatment of lung diseases | |
CA2044746A1 (en) | Polypeptide compound and a process for preparation thereof | |
DE69002385D1 (en) | ISOLATION AND STRUCTURAL DETERMINATION OF THE CYTOSTATIC LINEAR DEPSIPEPTID DOLASTATIN 15. | |
HK1003978A1 (en) | Composition for the treatment of schizophrenia | |
MXPA04003245A (en) | Hydroxypropylamines. | |
NZ504618A (en) | Controlled release therapeutic formulation for administering tolterodine maintaining a constant serum level | |
ZA883602B (en) | Medicament | |
CA2030433A1 (en) | New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases | |
KR0141913B1 (en) | Anti-virus agents | |
ATE223230T1 (en) | PULMONARY ADMINISTRATION OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 SCR1 | |
FI935847A (en) | L-DOPA ester compositions | |
DE69713148D1 (en) | CYCLOSPORINE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS | |
ATE194846T1 (en) | CYCLIC ANTIMICROBIAL PEPTIDES AND THEIR PRODUCTION | |
CA2392050A1 (en) | Pharmaceutical formulations containing zolmitriptan | |
WO2003005954B1 (en) | Methods and materials for the treatment of testosterone deficiency in men | |
DE68911891D1 (en) | Use of acetyl-L-carnitine for the treatment of cataracts, as well as pharmaceutical compositions for such a treatment. | |
HUT62192A (en) | Process for producing pharmaceutical compositions comprising tomoxetine and suitable for treating diseases of lower urinary tract | |
CA2135614A1 (en) | Use of urodilatin in pulmonary and bronchial diseases | |
ES555118A0 (en) | METHOD OF PREPARING MEDICINES INCLUDING A BONE SEARCH AGENT AND A CARBONIC ANHYDASE INHIBITOR, TO PREVENT AND CURE BONE DISEASES. | |
ES2111352T3 (en) | USE OF DIESTER PHOSPHATE FOR THE TREATMENT OF RETINAL DISEASES. | |
IT1258939B (en) | Linear or cyclic hexapeptide analogues of tachyquinine and their pharmaceutically acceptable salts, their preparation and pharmaceutical compositions containing them | |
EP0354568A3 (en) | Novel catechol derivatives | |
NZ332687A (en) | use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970627 |